fda warning about semaglutide Is GLP-1 Safe for Weight Loss? FDA adds warning to Wegovy

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 736 amide on gastric acid secretion in humans depends on an intact vagal innervation

Recent real-world research, including studies presented at the European Congress on Obesity, suggests that a slow taper off Wegovy combined with behavioral coaching can help maintain weight loss after medication cessation

Some of the primary genes impacted are COL1A1 (matrix), VEGFA (angiogenesis), IL6 (inflammation), and SOD2 (oxidative defense)

Avoid direct forceful streams onto the powder

Scurr LL, Pupo GM, Becker TM, Lai K, Schrama D, Haferkamp S et al

Sau A, Pellizzari Tregno F, Valentino F, Federici G, Caccuri AM